Clinical Trial Update: p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This report updates a Phase 2 clinical trial evaluating p53 gene therapy for diabetes in patients with hepatocellular carcinoma. The current status of the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hepatocellular Carcinoma

Drugs mentioned

• p53 gene therapy (p53 gene therapy)

Snippet

Sponsor: Shenzhen SiBiono GeneTech Co.,Ltd | Conditions: HCC, Diabetes | Phase 2 | Status: UNKNOWN